Skip to main content

Dual-Biomarker Algorithm Can Inform Osteoarthritis Diagnosis

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 19, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 19, 2024 -- A new diagnostic test using a dual-biomarker algorithm can inform osteoarthritis diagnosis with high accuracy, according to a study published online Dec. 18 in the Journal of Orthopaedic Research.

Daniel Keter, from CD Diagnostics in Claymont, Delaware, and colleagues developed a combinatorial algorithm using cartilage oligomeric matrix protein and interleukin-8 (IL-8) concentrations to differentiate primary osteoarthritis from inflammatory arthritis. A total of 171 human knee synovial fluid specimens were used to establish and validate clinical decision limits for cartilage oligomeric matrix protein concentration and the cartilage oligomeric matrix protein-to-IL-8 ratio.

The researchers found that clinical sensitivity and specificity were 87.0 and 88.9 percent, respectively, for the osteoarthritis algorithm, for overall accuracy of 88.3 percent. The osteoarthritis algorithm had an area under the curve of 0.93 in analysis of the receiver operating characteristic curve derived for the osteoarthritis algorithm ratios calculated on the primary osteoarthritis cohort versus the inflammatory arthritis cohort.

"Looking forward, differentiating primary osteoarthritis from other inflammatory arthritis types contributes towards better diagnosis that enables accurate, and targeted treatment of primary osteoarthritis," the authors write.

All authors are paid employees of CD Diagnostics or CD Laboratories, which are subsidiaries of Zimmer Biomet. Several authors disclosed financial ties to Zimmer Biomet, which funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

SARS-CoV-2 Infection Linked to More Rapid Plaque Growth in Lesions

MONDAY, Feb. 10, 2025 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary artery lesion-based plaque...

Childhood Maltreatment May Up Risk for Immune-Mediated Inflammatory Disorders

THURSDAY, Jan. 23, 2025 -- On a global scale, childhood maltreatment is associated with a higher risk for developing some immune-mediated inflammatory disorders (IMIDs), according...

Most Children With Multisystem Inflammatory Syndrome Recover by Six Months

WEDNESDAY, Jan. 15, 2025 -- Most children with multisystem inflammatory syndrome in children (MIS-C) recover quickly, according to a study published online Jan. 13 in JAMA...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Discover a treatment option for Eczema